Polar Capital’s Ionis Pharmaceuticals IONS Stock Holding History

Polar Capital’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-50,000	Closed	-$3M	–	297
2019 Q3	$3M	Sell	50,000 -50,000	-50%	-$3.26M	0.03%	246
2019 Q2	$6.43M	Buy	+100,000	New	+$7.07M	0.06%	218
2017 Q1	–	Sell	-210,000	Closed	-$10M	–	259
2016 Q4	$10M	Buy	+210,000	New	+$8.31M	0.16%	155
2016 Q1	–	Sell	-8,727	Closed	-$540K	–	274
2015 Q4	$540K	Buy	+8,727	New	+$471K	0.01%	247
2014 Q3	–	Sell	-8,994	Closed	-$310K	–	276
2014 Q2	$310K	Buy	+8,994	New	+$283K	0.01%	258

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Polar Capital's IONS Position: Q4 2019 in Review

Polar Capital sold out of Ionis Pharmaceuticals (IONS) in Q4 2019, closing a stake of 50,000 shares — an estimated $3M sold.

Polar Capital first reported a position in IONS in Q2 2014 and held it in 5 quarters. The position peaked at $10M in Q4 2016. 390 funds tracked by Wall St. Rank hold IONS as of Q4 2019.

Polar Capital reported no remaining Ionis Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
Polar Capital sold 50,000 Ionis Pharmaceuticals shares in Q4 2019, an estimated $3M.
Polar Capital first reported a position in Ionis Pharmaceuticals in Q2 2014 and held it in 5 quarters.
Polar Capital's Ionis Pharmaceuticals position peaked at $10M in Q4 2016.
390 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2019.

Based on Polar Capital's 13F filing for Q4 2019, filed 14 Feb 2020.